You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

November 2002

Volume 54, Issue 5

Pages 449–553

  1. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
      Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration (pages 449–452)

      Alfred E. Corey, Jeffrey R. Agnew, Suzanne N. Valentine, Nikhil J. Parekh, James H. Powell and Gary A. Thompson

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01664.x

    2. You have free access to this content
      Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers (pages 453–462)

      Yasuhiko Ikeda, Kazuo Umemura, Kazunao Kondo, Mitsuyoshi Nakashima, Takuo Kobayashi and Mitsuru Takahashi

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01676.x

    3. You have free access to this content
      Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide) (pages 463–471)

      Charlotte Van Kesteren, R. A. A. Mathôt, E. Raymond, J. P. Armand, P. Fumoleau, C. Punt, M. Ravic, J. Wanders, J. H. Beijnen and J. H. M. Schellens

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01684.x

  2. Pharmacokinetics/Pharmacodynamics

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
    2. You have free access to this content
      Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers (pages 478–484)

      Donna Donigi Gale, Linda J. Landells, Domenico Spina, Alan J. Miller, Kate Smith, Terry Nichols, Yakov Rotshteyn, Alfred Tonelli, Peter Lacouture, Ronald M. Burch, Clive P. Page and Brian J. O'Connor

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01682.x

    3. You have free access to this content
  3. Drug Metabolism

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
    2. You have free access to this content
      The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women (pages 504–510)

      Anna Nordmark, Stefan Lundgren, Birgitta Ask, Fredrik Granath and Anders Rane

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01673.x

    3. You have free access to this content
      Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism (pages 511–517)

      Ryoko Yoshida, Miki Nakajima, Yuki Watanabe, Jun-Tack Kwon and Tsuyoshi Yokoi

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01667.x

    4. You have free access to this content
  4. Pharmacovigilance

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
  5. Short Reports

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
      Drug reimbursement: Indicators of inappropriate resource allocation (pages 528–534)

      Bernard Bégaud, Ulf Bergman, Hans-Georg Eichler, Hubert G. M. Leufkens and Peter J. Meier

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01690.x

    2. You have free access to this content
      Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration (pages 535–539)

      Marcella Grundmann-Kollmann, Maurizio Podda, Lutz Bräutigam, Katja Hardt-Weinelt, Ralf J. Ludwig, Gerd Geisslinger, Roland Kaufmann and Irmgard Tegeder

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01692.x

    3. You have free access to this content
      Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2 (pages 540–543)

      Xing-Mei Han, Dong-Sheng Ouyang, Xiao-Ping Chen, Yan Shu, Chang-Hong Jiang, Zhi-Rong Tan and Hong-Hao Zhou

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01686.x

    4. You have free access to this content
      Effect of plastic spacer handling on salbutamol lung deposition in asthmatic children (pages 544–547)

      Brian J. Lipworth, Daniel K. C. Lee, Jacob Anhøj and Hans Bisgaard

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01675.x

  6. Letter

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
      Prevalence of factitious hypoglycaemia associated with sulphonylurea drugs in France in the year 2000 (page 548)

      T. Trenque, C. Frances, H. Millart, G. Hoizey and M. L. Germain

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.01685.x

  7. Letters to the Editors

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
  8. Letter to the Editors

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
  9. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002

    1. Top of page
    2. Pharmacokinetics
    3. Pharmacokinetics/Pharmacodynamics
    4. Drug Metabolism
    5. Pharmacovigilance
    6. Short Reports
    7. Letter
    8. Letters to the Editors
    9. Letter to the Editors
    10. Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy 19 April 2002
    1. You have free access to this content
      The effect of CYP2C19 polymorphism on the pharmacokinetics and acid-inhibitory effects of oral lansoprazole and omeprazole (page 553)

      C. H. J. BEKKERS, D. J. TOUW, C. B. H. W. LAMERS and W. P. GEUS

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.t01-7-01714.x

SEARCH

SEARCH BY CITATION